IP Library Granted Patent US 7,189,837
Granted Patent B2
US 7,189,837 · App. 10/341,836 · Granted Mar 13, 2007

Cell surface molecule-induced macrophage activation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,189,837
App. No.
10/341,836
Granted
Mar 13, 2007
Kind
B2
Abstract

This invention provides compositions, such as capsules, comprising transformed cells that express immunostimulatory cell surface polypeptides which are expressed on the cell surface and are capable of stimulating an immune response against the cell in a host.

Claims (11)

1. A composition comprising:

(a) a core comprising a transformed cell containing a recombinant polynucleotide comprising a promoter operably linked with a polynucleotide sequence encoding a fusion protein comprising the Fc portion of an IgG molecule linked to a cell surface protein, selected from the group consisting of transferrin, CD10, CD13, CD23, CD26, CD38, CD71, CD72, CD74, lymphocyte activation antigen 4F2, B-lymphocyte differentiation antigen BP-1, endoglin cell surface antigen, natural killer cell lectin-like Ly-49, macrophage asialoglycoprotein binding protein, natural killer cell lectin-like receptor NKG2A, natural killer cell lectin-like receptor NKR-PI, and plasma cell membrane antigen PC-1, which anchors the fusion protein to the cell surface, such that, upon expression of the fusion protein on the celIsurface, the Fc portion of the fusion protein is capable of stimulating an immune response against the cell in a host wherein said stimulation occurs without complement fixation; and

(b) a jacket surrounding the core, the jacket comprising a permselective membrane.

2. The composition of claim 1 , wherein said immune response is the activation of phagocytes.

3. A composition comprising:

(a) a core comprising a transformed cell containing a recombinant polynucleotide comprising a promoter operably linked with a polynucleotide sequence encoding a fusion protein comprising the Fc portion of an IgG molecule linked at the amino terminus to the transferrin receptor hinge region wherein upon expression of the fusion protein on the cell surface, the Fc portion of the fusion protein is capable of stimulating an immune response against the cell in a host wherein said stimulation occurs without complement fixation; and

(b) a jacket surrounding the core, the jacket comprising a permselective membrane.

4. The composition of claim 3 , wherein said immune response is the activation of phagocytes.

5. A composition comprising:

(a) a core comprising a transformed cell containing a recombinant polynucleotide comprising a promoter operably linked with a polynucleotide sequence encoding a fusion protein comprising the Fc portion of an IgG molecule linked at the amino terminus to the transferrin receptor hinge region, wherein upon expression, the fusion protein is expressed on the cell surface; and

(b) a jacket surrounding the core, the jacket comprising a permselective membrane.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2008
From: NEUROTECH, S.A.
To: NEUROTECH USA, INC.
Reel/Frame 020487/0321 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2006
From: TAO, WENG; WONG, SHOU; HICKEY, WILLIAM F.; HAMMANG, JOSEPH P.; BAETGE, E. EDWARD
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 018217/0910 →